Symbols

NPCE

NeuroPace·NASDAQ

--(--)

NPCE Profile

Neuropace, Inc.

A commercial stage medical device company focused on solutions for epilepsy

Industry

Healthcare Equipment and Supplies

Established Date

11/19/1997

Listing Date

04/22/2021

Exchange

NASDAQ Stock Exchange

Full-time Employees

209

Fiscal Year Ends

12-31

Website

www.neuropace.com

Security Type

Common stock

Office address

455 N. Bernardo Avenue, Mountain View, CA 94043

Business

Introduction

NeuroPace, Inc., was incorporated in Delaware on November 19, 1997. The company is a medical device company focused on the treatment of epilepsy, and its RNS system is a brain reactive neuromodulation platform capable of providing personalized real-time treatment at the source of epileptic seizures. This is the first and only commercialized system of its kind designed to reduce or eliminate disruptive seizures in patients with refractory epilepsy.